Agilent Technologies Inc.
Agilent Technologies Announces CFO Resignation and Interim CFO Appointment
Summary
On July 15, 2025, Agilent Technologies, Inc. announced the resignation of Robert W. McMahon as Senior Vice President and Chief Financial Officer. Rodeny Gonsalves has been appointed as interim Chief Financial Officer and interim Principal Financial Officer, effective July 31, 2025. The Compensation Committee approved a bi-weekly salary stipend of $8,654 for Mr. Gonsalves and a grant of restricted stock units valued at $1,000,000, subject to the company's equity award terms.
Profitelligence Alerts
Get alerts for A
Be first to know when Agilent Technologies Inc. files with the SEC.
Filing Categories
Advertisement
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Official SEC Documents
Advertisement